Vaxart, Inc. (VXRT)
0.6122
-0.01
(-1.26%)
USD |
OTCM |
Apr 08, 15:49
Vaxart Cash from Investing (TTM) : 16.63M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 14.04M |
| Nuwellis, Inc. | -0.09M |
| Capricor Therapeutics, Inc. | 97.48M |
| Allogene Therapeutics, Inc. | 95.56M |
| Silvergate Capital Corp. | -- |